Factors Associated with Virological Rebound in HIV-Positive Sub-Saharan Migrants Living in France After Traveling Back to Their Native Country: ANRS-VIHVO 2006–2009 Study

In France, around 25% of the estimated number of people living with HIV are migrants, of whom three quarters are from sub-Saharan Africa (SSA). Our objective was to determine factors associated with virological rebound (VR) at the occasion of a transient stay to the country of origin. HIV-positive m...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of immigrant and minority health 2019-12, Vol.21 (6), p.1342-1348
Hauptverfasser: Kankou, Jean-Médard, Bouchaud, Olivier, Lele, Nathalie, Guiguet, Marguerite, Spire, Bruno, Carrieri, Maria Patrizia, Abgrall, Sophie
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1348
container_issue 6
container_start_page 1342
container_title Journal of immigrant and minority health
container_volume 21
creator Kankou, Jean-Médard
Bouchaud, Olivier
Lele, Nathalie
Guiguet, Marguerite
Spire, Bruno
Carrieri, Maria Patrizia
Abgrall, Sophie
description In France, around 25% of the estimated number of people living with HIV are migrants, of whom three quarters are from sub-Saharan Africa (SSA). Our objective was to determine factors associated with virological rebound (VR) at the occasion of a transient stay to the country of origin. HIV-positive migrants from SSA participating to the ANRS-VIHVO adherence study between 2006 and 2009, on effective ART with controlled pre-travel HIV-1 plasma viral load (VL), were included. Outcome was VR, defined as VL ≥ 50 copies/ml at the post-travel visit during the week following the return to France. Among 237 persons (61.6% female, median age 41 years (IQR, 35–47), median time on ART 4.2 years (IQR, 2.2–7.1), 27 (11.4%) experienced VR. The main purpose of the travel was to visit family and median time spent abroad was 5.3 weeks (IQR, 4.1–8.8). The travel was extended longer than anticipated by at least 1 week in 42 individuals (17.7%). In multivariable logistic model, risk factors for VR were male sex [adjusted OR (aOR) 5.1; 95% CI 1.6–16.2)], no employment in France (aOR 2.0; 1.2–3.5), self-reported non-adherence during the trip (aOR 14.9; 4.9–45.9) and PI-containing regimen (aOR 4.6; 1.2–17.6). In another analysis not including self-reported adherence, traveling during Ramadan while respecting the fast (aOR 3.3; 1.2–9.6) and extension of the stay (aOR 3.0; 1.1–7.8) were associated with VR. Virological rebound was partly explained by structural barriers to adherence such as extension of the travel and inadequate management of Ramadan fasting. Individuals’journeys should be carefully planned with health care providers.
doi_str_mv 10.1007/s10903-019-00864-y
format Article
fullrecord <record><control><sourceid>jstor_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_02178772v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>48709631</jstor_id><sourcerecordid>48709631</sourcerecordid><originalsourceid>FETCH-LOGICAL-c475t-30a5fe0c4f8508477970a9e22fa8804f4f6c4cba1484bce3f5840ac1919d33973</originalsourceid><addsrcrecordid>eNp9ks-O0zAQxiMEYpeFF0ACWeICh8A4dmLnWCpKVyp_xJa9WlPXaV3SeNd2ivoSPDPOZikSB05jzfzmm7E_Z9lzCm8pgHgXKNTAcqB1DiArnh8fZOe0LEVO6wIens60OMuehLAD4FQW8Dg7YyDqqpL0PPs1Qx2dD2QSgtMWo1mTnzZuybX1rnUbq7El38zK9d2a2I7ML6_zry7YaA-GXPWr_Aq36LEjn-wmhRjIwh5stxnYWUpoQyZNNJ4sPR5MO1Teo_5BoiPLrbGefMY7qWkaEP3xafaowTaYZ_fxIvs--7CczvPFl4-X08ki11yUMWeAZWNA80aWILkQtQCsTVE0KCXwhjeV5nqFlEu-0oY1peSAOj1FvWasFuwiezPqbrFVN97u0R-VQ6vmk4UaclBQIYUoDjSxr0f2xrvb3oSo9jZo07bYGdcHVVBZlhVIGGRf_YPuXO-7dJOB4jKtUQ6CxUhp70LwpjltQEENzqrRWZWcVXfOqmNqenkv3a_2Zn1q-WNlAtgIhFTqNsb_nf1f2Rdj1y6kb3BS5VJAXTHKfgOg57en</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2184858451</pqid></control><display><type>article</type><title>Factors Associated with Virological Rebound in HIV-Positive Sub-Saharan Migrants Living in France After Traveling Back to Their Native Country: ANRS-VIHVO 2006–2009 Study</title><source>MEDLINE</source><source>Sociological Abstracts</source><source>Applied Social Sciences Index &amp; Abstracts (ASSIA)</source><source>Jstor Complete Legacy</source><source>SpringerLink Journals - AutoHoldings</source><creator>Kankou, Jean-Médard ; Bouchaud, Olivier ; Lele, Nathalie ; Guiguet, Marguerite ; Spire, Bruno ; Carrieri, Maria Patrizia ; Abgrall, Sophie</creator><creatorcontrib>Kankou, Jean-Médard ; Bouchaud, Olivier ; Lele, Nathalie ; Guiguet, Marguerite ; Spire, Bruno ; Carrieri, Maria Patrizia ; Abgrall, Sophie ; ANRS-VIHVO Study Group</creatorcontrib><description>In France, around 25% of the estimated number of people living with HIV are migrants, of whom three quarters are from sub-Saharan Africa (SSA). Our objective was to determine factors associated with virological rebound (VR) at the occasion of a transient stay to the country of origin. HIV-positive migrants from SSA participating to the ANRS-VIHVO adherence study between 2006 and 2009, on effective ART with controlled pre-travel HIV-1 plasma viral load (VL), were included. Outcome was VR, defined as VL ≥ 50 copies/ml at the post-travel visit during the week following the return to France. Among 237 persons (61.6% female, median age 41 years (IQR, 35–47), median time on ART 4.2 years (IQR, 2.2–7.1), 27 (11.4%) experienced VR. The main purpose of the travel was to visit family and median time spent abroad was 5.3 weeks (IQR, 4.1–8.8). The travel was extended longer than anticipated by at least 1 week in 42 individuals (17.7%). In multivariable logistic model, risk factors for VR were male sex [adjusted OR (aOR) 5.1; 95% CI 1.6–16.2)], no employment in France (aOR 2.0; 1.2–3.5), self-reported non-adherence during the trip (aOR 14.9; 4.9–45.9) and PI-containing regimen (aOR 4.6; 1.2–17.6). In another analysis not including self-reported adherence, traveling during Ramadan while respecting the fast (aOR 3.3; 1.2–9.6) and extension of the stay (aOR 3.0; 1.1–7.8) were associated with VR. Virological rebound was partly explained by structural barriers to adherence such as extension of the travel and inadequate management of Ramadan fasting. Individuals’journeys should be carefully planned with health care providers.</description><identifier>ISSN: 1557-1912</identifier><identifier>EISSN: 1557-1920</identifier><identifier>DOI: 10.1007/s10903-019-00864-y</identifier><identifier>PMID: 30796681</identifier><language>eng</language><publisher>New York: Springer Science + Business Media</publisher><subject>Adherence ; Adhesion ; Adult ; Africa South of the Sahara - ethnology ; Anti-HIV Agents - therapeutic use ; Antiretroviral drugs ; Antiretroviral therapy ; Comparative Law ; Country of origin ; Employment ; Fasting ; Female ; France - epidemiology ; Health care ; Health care industry ; Health services ; HIV ; HIV Infections - ethnology ; HIV Infections - virology ; Human immunodeficiency virus ; Humans ; International &amp; Foreign Law ; Life Sciences ; Male ; Medical personnel ; Medication Adherence - ethnology ; Medication Adherence - psychology ; Medication Adherence - statistics &amp; numerical data ; Medicine ; Medicine &amp; Public Health ; Middle Aged ; Migrants ; Original Paper ; Other Articles ; Private International Law ; Public Health ; Ramadan ; Risk analysis ; Risk Factors ; Santé publique et épidémiologie ; Sexually transmitted diseases ; Sociology ; STD ; Travel ; Trip estimation ; Viral Load</subject><ispartof>Journal of immigrant and minority health, 2019-12, Vol.21 (6), p.1342-1348</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2019</rights><rights>Journal of Immigrant and Minority Health is a copyright of Springer, (2019). All Rights Reserved.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c475t-30a5fe0c4f8508477970a9e22fa8804f4f6c4cba1484bce3f5840ac1919d33973</citedby><cites>FETCH-LOGICAL-c475t-30a5fe0c4f8508477970a9e22fa8804f4f6c4cba1484bce3f5840ac1919d33973</cites><orcidid>0000-0002-7891-7594 ; 0000-0001-6800-0742 ; 0000-0002-6794-4837</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/48709631$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/48709631$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>230,314,776,780,799,881,12826,27323,27903,27904,30978,33753,41467,42536,51297,57995,58228</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30796681$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.sorbonne-universite.fr/hal-02178772$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Kankou, Jean-Médard</creatorcontrib><creatorcontrib>Bouchaud, Olivier</creatorcontrib><creatorcontrib>Lele, Nathalie</creatorcontrib><creatorcontrib>Guiguet, Marguerite</creatorcontrib><creatorcontrib>Spire, Bruno</creatorcontrib><creatorcontrib>Carrieri, Maria Patrizia</creatorcontrib><creatorcontrib>Abgrall, Sophie</creatorcontrib><creatorcontrib>ANRS-VIHVO Study Group</creatorcontrib><title>Factors Associated with Virological Rebound in HIV-Positive Sub-Saharan Migrants Living in France After Traveling Back to Their Native Country: ANRS-VIHVO 2006–2009 Study</title><title>Journal of immigrant and minority health</title><addtitle>J Immigrant Minority Health</addtitle><addtitle>J Immigr Minor Health</addtitle><description>In France, around 25% of the estimated number of people living with HIV are migrants, of whom three quarters are from sub-Saharan Africa (SSA). Our objective was to determine factors associated with virological rebound (VR) at the occasion of a transient stay to the country of origin. HIV-positive migrants from SSA participating to the ANRS-VIHVO adherence study between 2006 and 2009, on effective ART with controlled pre-travel HIV-1 plasma viral load (VL), were included. Outcome was VR, defined as VL ≥ 50 copies/ml at the post-travel visit during the week following the return to France. Among 237 persons (61.6% female, median age 41 years (IQR, 35–47), median time on ART 4.2 years (IQR, 2.2–7.1), 27 (11.4%) experienced VR. The main purpose of the travel was to visit family and median time spent abroad was 5.3 weeks (IQR, 4.1–8.8). The travel was extended longer than anticipated by at least 1 week in 42 individuals (17.7%). In multivariable logistic model, risk factors for VR were male sex [adjusted OR (aOR) 5.1; 95% CI 1.6–16.2)], no employment in France (aOR 2.0; 1.2–3.5), self-reported non-adherence during the trip (aOR 14.9; 4.9–45.9) and PI-containing regimen (aOR 4.6; 1.2–17.6). In another analysis not including self-reported adherence, traveling during Ramadan while respecting the fast (aOR 3.3; 1.2–9.6) and extension of the stay (aOR 3.0; 1.1–7.8) were associated with VR. Virological rebound was partly explained by structural barriers to adherence such as extension of the travel and inadequate management of Ramadan fasting. Individuals’journeys should be carefully planned with health care providers.</description><subject>Adherence</subject><subject>Adhesion</subject><subject>Adult</subject><subject>Africa South of the Sahara - ethnology</subject><subject>Anti-HIV Agents - therapeutic use</subject><subject>Antiretroviral drugs</subject><subject>Antiretroviral therapy</subject><subject>Comparative Law</subject><subject>Country of origin</subject><subject>Employment</subject><subject>Fasting</subject><subject>Female</subject><subject>France - epidemiology</subject><subject>Health care</subject><subject>Health care industry</subject><subject>Health services</subject><subject>HIV</subject><subject>HIV Infections - ethnology</subject><subject>HIV Infections - virology</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>International &amp; Foreign Law</subject><subject>Life Sciences</subject><subject>Male</subject><subject>Medical personnel</subject><subject>Medication Adherence - ethnology</subject><subject>Medication Adherence - psychology</subject><subject>Medication Adherence - statistics &amp; numerical data</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Middle Aged</subject><subject>Migrants</subject><subject>Original Paper</subject><subject>Other Articles</subject><subject>Private International Law</subject><subject>Public Health</subject><subject>Ramadan</subject><subject>Risk analysis</subject><subject>Risk Factors</subject><subject>Santé publique et épidémiologie</subject><subject>Sexually transmitted diseases</subject><subject>Sociology</subject><subject>STD</subject><subject>Travel</subject><subject>Trip estimation</subject><subject>Viral Load</subject><issn>1557-1912</issn><issn>1557-1920</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>7QJ</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>BHHNA</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>LD-</sourceid><sourceid>LD.</sourceid><sourceid>M2O</sourceid><sourceid>QXPDG</sourceid><recordid>eNp9ks-O0zAQxiMEYpeFF0ACWeICh8A4dmLnWCpKVyp_xJa9WlPXaV3SeNd2ivoSPDPOZikSB05jzfzmm7E_Z9lzCm8pgHgXKNTAcqB1DiArnh8fZOe0LEVO6wIens60OMuehLAD4FQW8Dg7YyDqqpL0PPs1Qx2dD2QSgtMWo1mTnzZuybX1rnUbq7El38zK9d2a2I7ML6_zry7YaA-GXPWr_Aq36LEjn-wmhRjIwh5stxnYWUpoQyZNNJ4sPR5MO1Teo_5BoiPLrbGefMY7qWkaEP3xafaowTaYZ_fxIvs--7CczvPFl4-X08ki11yUMWeAZWNA80aWILkQtQCsTVE0KCXwhjeV5nqFlEu-0oY1peSAOj1FvWasFuwiezPqbrFVN97u0R-VQ6vmk4UaclBQIYUoDjSxr0f2xrvb3oSo9jZo07bYGdcHVVBZlhVIGGRf_YPuXO-7dJOB4jKtUQ6CxUhp70LwpjltQEENzqrRWZWcVXfOqmNqenkv3a_2Zn1q-WNlAtgIhFTqNsb_nf1f2Rdj1y6kb3BS5VJAXTHKfgOg57en</recordid><startdate>20191201</startdate><enddate>20191201</enddate><creator>Kankou, Jean-Médard</creator><creator>Bouchaud, Olivier</creator><creator>Lele, Nathalie</creator><creator>Guiguet, Marguerite</creator><creator>Spire, Bruno</creator><creator>Carrieri, Maria Patrizia</creator><creator>Abgrall, Sophie</creator><general>Springer Science + Business Media</general><general>Springer US</general><general>Springer Nature B.V</general><general>Springer Verlag</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7QJ</scope><scope>7RV</scope><scope>7T2</scope><scope>7U4</scope><scope>7WY</scope><scope>7WZ</scope><scope>7X7</scope><scope>7XB</scope><scope>87Z</scope><scope>88E</scope><scope>88G</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FL</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BEZIV</scope><scope>BHHNA</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWI</scope><scope>DWQXO</scope><scope>FRNLG</scope><scope>FYUFA</scope><scope>F~G</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HEHIP</scope><scope>K60</scope><scope>K6~</scope><scope>K9.</scope><scope>L.-</scope><scope>LD-</scope><scope>LD.</scope><scope>M0C</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2S</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQBIZ</scope><scope>PQBZA</scope><scope>PQEDU</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>QXPDG</scope><scope>WZK</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><orcidid>https://orcid.org/0000-0002-7891-7594</orcidid><orcidid>https://orcid.org/0000-0001-6800-0742</orcidid><orcidid>https://orcid.org/0000-0002-6794-4837</orcidid></search><sort><creationdate>20191201</creationdate><title>Factors Associated with Virological Rebound in HIV-Positive Sub-Saharan Migrants Living in France After Traveling Back to Their Native Country</title><author>Kankou, Jean-Médard ; Bouchaud, Olivier ; Lele, Nathalie ; Guiguet, Marguerite ; Spire, Bruno ; Carrieri, Maria Patrizia ; Abgrall, Sophie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c475t-30a5fe0c4f8508477970a9e22fa8804f4f6c4cba1484bce3f5840ac1919d33973</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adherence</topic><topic>Adhesion</topic><topic>Adult</topic><topic>Africa South of the Sahara - ethnology</topic><topic>Anti-HIV Agents - therapeutic use</topic><topic>Antiretroviral drugs</topic><topic>Antiretroviral therapy</topic><topic>Comparative Law</topic><topic>Country of origin</topic><topic>Employment</topic><topic>Fasting</topic><topic>Female</topic><topic>France - epidemiology</topic><topic>Health care</topic><topic>Health care industry</topic><topic>Health services</topic><topic>HIV</topic><topic>HIV Infections - ethnology</topic><topic>HIV Infections - virology</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>International &amp; Foreign Law</topic><topic>Life Sciences</topic><topic>Male</topic><topic>Medical personnel</topic><topic>Medication Adherence - ethnology</topic><topic>Medication Adherence - psychology</topic><topic>Medication Adherence - statistics &amp; numerical data</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Middle Aged</topic><topic>Migrants</topic><topic>Original Paper</topic><topic>Other Articles</topic><topic>Private International Law</topic><topic>Public Health</topic><topic>Ramadan</topic><topic>Risk analysis</topic><topic>Risk Factors</topic><topic>Santé publique et épidémiologie</topic><topic>Sexually transmitted diseases</topic><topic>Sociology</topic><topic>STD</topic><topic>Travel</topic><topic>Trip estimation</topic><topic>Viral Load</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kankou, Jean-Médard</creatorcontrib><creatorcontrib>Bouchaud, Olivier</creatorcontrib><creatorcontrib>Lele, Nathalie</creatorcontrib><creatorcontrib>Guiguet, Marguerite</creatorcontrib><creatorcontrib>Spire, Bruno</creatorcontrib><creatorcontrib>Carrieri, Maria Patrizia</creatorcontrib><creatorcontrib>Abgrall, Sophie</creatorcontrib><creatorcontrib>ANRS-VIHVO Study Group</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>Applied Social Sciences Index &amp; Abstracts (ASSIA)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Sociological Abstracts (pre-2017)</collection><collection>ABI/INFORM Collection</collection><collection>ABI/INFORM Global (PDF only)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ABI/INFORM Global (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection (Alumni Edition)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Social Science Premium Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Business Premium Collection</collection><collection>Sociological Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Sociological Abstracts</collection><collection>ProQuest Central Korea</collection><collection>Business Premium Collection (Alumni)</collection><collection>Health Research Premium Collection</collection><collection>ABI/INFORM Global (Corporate)</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>Sociology Collection</collection><collection>ProQuest Business Collection (Alumni Edition)</collection><collection>ProQuest Business Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ABI/INFORM Professional Advanced</collection><collection>Ethnic NewsWatch</collection><collection>Ethnic NewsWatch (Alumni)</collection><collection>ABI/INFORM Global</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Research Library</collection><collection>Sociology Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Business</collection><collection>ProQuest One Business (Alumni)</collection><collection>ProQuest One Education</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>Diversity Collection</collection><collection>Sociological Abstracts (Ovid)</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><jtitle>Journal of immigrant and minority health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kankou, Jean-Médard</au><au>Bouchaud, Olivier</au><au>Lele, Nathalie</au><au>Guiguet, Marguerite</au><au>Spire, Bruno</au><au>Carrieri, Maria Patrizia</au><au>Abgrall, Sophie</au><aucorp>ANRS-VIHVO Study Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Factors Associated with Virological Rebound in HIV-Positive Sub-Saharan Migrants Living in France After Traveling Back to Their Native Country: ANRS-VIHVO 2006–2009 Study</atitle><jtitle>Journal of immigrant and minority health</jtitle><stitle>J Immigrant Minority Health</stitle><addtitle>J Immigr Minor Health</addtitle><date>2019-12-01</date><risdate>2019</risdate><volume>21</volume><issue>6</issue><spage>1342</spage><epage>1348</epage><pages>1342-1348</pages><issn>1557-1912</issn><eissn>1557-1920</eissn><abstract>In France, around 25% of the estimated number of people living with HIV are migrants, of whom three quarters are from sub-Saharan Africa (SSA). Our objective was to determine factors associated with virological rebound (VR) at the occasion of a transient stay to the country of origin. HIV-positive migrants from SSA participating to the ANRS-VIHVO adherence study between 2006 and 2009, on effective ART with controlled pre-travel HIV-1 plasma viral load (VL), were included. Outcome was VR, defined as VL ≥ 50 copies/ml at the post-travel visit during the week following the return to France. Among 237 persons (61.6% female, median age 41 years (IQR, 35–47), median time on ART 4.2 years (IQR, 2.2–7.1), 27 (11.4%) experienced VR. The main purpose of the travel was to visit family and median time spent abroad was 5.3 weeks (IQR, 4.1–8.8). The travel was extended longer than anticipated by at least 1 week in 42 individuals (17.7%). In multivariable logistic model, risk factors for VR were male sex [adjusted OR (aOR) 5.1; 95% CI 1.6–16.2)], no employment in France (aOR 2.0; 1.2–3.5), self-reported non-adherence during the trip (aOR 14.9; 4.9–45.9) and PI-containing regimen (aOR 4.6; 1.2–17.6). In another analysis not including self-reported adherence, traveling during Ramadan while respecting the fast (aOR 3.3; 1.2–9.6) and extension of the stay (aOR 3.0; 1.1–7.8) were associated with VR. Virological rebound was partly explained by structural barriers to adherence such as extension of the travel and inadequate management of Ramadan fasting. Individuals’journeys should be carefully planned with health care providers.</abstract><cop>New York</cop><pub>Springer Science + Business Media</pub><pmid>30796681</pmid><doi>10.1007/s10903-019-00864-y</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-7891-7594</orcidid><orcidid>https://orcid.org/0000-0001-6800-0742</orcidid><orcidid>https://orcid.org/0000-0002-6794-4837</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1557-1912
ispartof Journal of immigrant and minority health, 2019-12, Vol.21 (6), p.1342-1348
issn 1557-1912
1557-1920
language eng
recordid cdi_hal_primary_oai_HAL_hal_02178772v1
source MEDLINE; Sociological Abstracts; Applied Social Sciences Index & Abstracts (ASSIA); Jstor Complete Legacy; SpringerLink Journals - AutoHoldings
subjects Adherence
Adhesion
Adult
Africa South of the Sahara - ethnology
Anti-HIV Agents - therapeutic use
Antiretroviral drugs
Antiretroviral therapy
Comparative Law
Country of origin
Employment
Fasting
Female
France - epidemiology
Health care
Health care industry
Health services
HIV
HIV Infections - ethnology
HIV Infections - virology
Human immunodeficiency virus
Humans
International & Foreign Law
Life Sciences
Male
Medical personnel
Medication Adherence - ethnology
Medication Adherence - psychology
Medication Adherence - statistics & numerical data
Medicine
Medicine & Public Health
Middle Aged
Migrants
Original Paper
Other Articles
Private International Law
Public Health
Ramadan
Risk analysis
Risk Factors
Santé publique et épidémiologie
Sexually transmitted diseases
Sociology
STD
Travel
Trip estimation
Viral Load
title Factors Associated with Virological Rebound in HIV-Positive Sub-Saharan Migrants Living in France After Traveling Back to Their Native Country: ANRS-VIHVO 2006–2009 Study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T07%3A14%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Factors%20Associated%20with%20Virological%20Rebound%20in%20HIV-Positive%20Sub-Saharan%20Migrants%20Living%20in%20France%20After%20Traveling%20Back%20to%20Their%20Native%20Country:%20ANRS-VIHVO%202006%E2%80%932009%20Study&rft.jtitle=Journal%20of%20immigrant%20and%20minority%20health&rft.au=Kankou,%20Jean-M%C3%A9dard&rft.aucorp=ANRS-VIHVO%20Study%20Group&rft.date=2019-12-01&rft.volume=21&rft.issue=6&rft.spage=1342&rft.epage=1348&rft.pages=1342-1348&rft.issn=1557-1912&rft.eissn=1557-1920&rft_id=info:doi/10.1007/s10903-019-00864-y&rft_dat=%3Cjstor_hal_p%3E48709631%3C/jstor_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2184858451&rft_id=info:pmid/30796681&rft_jstor_id=48709631&rfr_iscdi=true